About Quest Diagnostics
Quest Diagnostics is a Healthcare company based in Los Angeles (United States) founded in 1998, and was acquired by Quest Diagnostics in March 2011. Molecular diagnostic products for disease detection and treatment are developed. It operates on a Managed Services, Pay-per-Use / Usage-Based, and HealthTech model. Quest Diagnostics has completed 1 acquisition, including Axys Pharmaceuticals. Quest Diagnostics offers products and services including Lab Testing Services, QUEST AD-Detect Amyloid Beta 42/40, and COVID-19 Testing. Its focus areas include Diagnostics and Clinical Laboratory Services. Its legal entity is Quest Diagnostics Incorporated. Its competitors include Inflammatix, Agendia and PathogenDX; 3 of its 3 listed competitors have raised funding.
Company details
Diagnostic testing services are offered by Quest Diagnostics across various health sectors. Comprehensive lab tests are conducted for conditions like cancer, diabetes, and infectious diseases. Solutions for hospitals, employers, and health plans are provided to optimize care and manage costs. Collaborations with academic institutions are maintained for medical research. Advanced technology and clinical expertise are integrated to support patient outcomes in multiple industries.
- Headquarters Los Angeles, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website celera.com
- Social LinkedIn
- Acquired by Quest Diagnostics (Mar 2011)
- Legal Name Quest Diagnostics Incorporated
- Investors
- Investments & Acquisitions
- Acquired byQuest Diagnostics
(Mar 2011)
Products & Services of Quest Diagnostics
Quest Diagnostics offers a comprehensive portfolio of products and services, including Lab Testing Services, QUEST AD-Detect Amyloid Beta 42/40, and COVID-19 Testing.
Lab tests are provided for various health conditions.
Blood-based testing is offered for early Alzheimer’s detection.
Molecular and antigen tests are provided for COVID-19.
Investors in Quest Diagnostics
Quest Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Quest Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Integrated diagnostic and IT services are provided to healthcare organizations. | 1967 | questdiagnostics.com | Madison, United States |
Investor details for Quest Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quest Diagnostics
Quest Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Axys Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Protease-based drugs developed for cancer and autoimmune diseases. | axyspharm.com | San Francisco, United States | 1998 | Jun 2001 | $173.4M |
Complete acquisition details for Quest Diagnostics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Quest Diagnostics
3 dated milestones of Quest Diagnostics across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Quest Diagnostics is founded.
- Acquisition Acquires Axys Pharmaceuticals.
- Exit Acquired by Quest Diagnostics.
Competitors of Quest Diagnostics
Quest Diagnostics has 3 listed competitors in our database, 3 of them funded. They include Inflammatix, Agendia and PathogenDX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| agendia.com | 2003 | Irvine, United States | $123M | 203 | Genomic diagnostic products for cancer treatment are provided. | |
| pathogendx.com | 2014 | Tucson, United States | $11.58M | 31 | Provider of DNA-based pathogen testing kits |
Detailed competitors of Quest Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Quest Diagnostics
Websites that share an audience with Quest Diagnostics (celera.com).
Websites whose visitors overlap most with Quest Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sanger.ac.uk | 100% | 257.8K | #169,901 | View details | |
| novozymes.com | 84% | 92.7K | #445,856 | View details | |
genome.ucsc.edu | genome.ucsc.edu | 80% | – | ||
| completegenomics.com | 80% | 11.4K | #2,001,051 | View details | |
| genomenewsnetwork.org | 80% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Quest Diagnostics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Quest Diagnostics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Quest Diagnostics
Complete news archive for Quest Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quest Diagnostics
Quest Diagnostics was founded in 1998.
Quest Diagnostics is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Diagnostic testing services are offered by Quest Diagnostics across various health sectors. Comprehensive lab tests are conducted for conditions like cancer, diabetes, and infectious diseases. Solutions for hospitals, employers, and health plans are provided to optimize care and manage costs. Collaborations with academic institutions are maintained for medical research. Advanced technology and clinical expertise are integrated to support patient outcomes in multiple industries.
Quest Diagnostics's top competitors include Inflammatix, PathogenDX and Agendia.
Quest Diagnostics offers Lab Testing Services, QUEST AD-Detect Amyloid Beta 42/40, and COVID-19 Testing.
Quest Diagnostics has made 1 acquisition, including Axys Pharmaceuticals.
Quest Diagnostics has 1 investor. Key investors include Quest Diagnostics.
Quest Diagnostics operates through Quest Diagnostics Incorporated.
Yes. Quest Diagnostics was acquired by Quest Diagnostics in March 2011.